(Q38423122)

English

Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay

scientific article published on 25 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay (English)

1 reference

Europe PubMed Central

3 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lisa D Schlehuber

1

1 reference

Europe PubMed Central

3 September 2017

Iain J McFadyen

2

1 reference

Europe PubMed Central

3 September 2017

Yu Shu

3

1 reference

Europe PubMed Central

3 September 2017

James Carignan

4

1 reference

Europe PubMed Central

3 September 2017

W Paul Duprex

5

1 reference

Europe PubMed Central

3 September 2017

William R Forsyth

6

1 reference

Europe PubMed Central

3 September 2017

Jason H Ho

7

1 reference

Europe PubMed Central

3 September 2017

Christine M Kitsos

8

1 reference

Europe PubMed Central

3 September 2017

George Y Lee

9

1 reference

Europe PubMed Central

3 September 2017

Douglas A Levinson

10

1 reference

Europe PubMed Central

3 September 2017

Sarah C Lucier

11

1 reference

Europe PubMed Central

3 September 2017

Christopher B Moore

12

1 reference

Europe PubMed Central

3 September 2017

Niem T Nguyen

13

1 reference

Europe PubMed Central

3 September 2017

Josephine Ramos

14

1 reference

Europe PubMed Central

3 September 2017

B André Weinstock

15

1 reference

Europe PubMed Central

3 September 2017

Junhong Zhang

16

1 reference

Europe PubMed Central

3 September 2017

Julie A Monagle

17

1 reference

Europe PubMed Central

3 September 2017

Colin R Gardner

18

1 reference

Europe PubMed Central

3 September 2017

Juan C Alvarez

19

1 reference

Europe PubMed Central

3 September 2017

language of work or name

0 references

publication date

25 May 2011

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

29

1 reference

Europe PubMed Central

3 September 2017

31

1 reference

Europe PubMed Central

3 September 2017

5031-5039

1 reference

Europe PubMed Central

3 September 2017

Growth and stability of measles virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Stabilising oral poliovaccine at high ambient temperatures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Monitoring the vaccine cold chain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Measles in children previously vaccinated against measles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Vaccine storage practices in primary care physician offices: assessment and intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

System-level determinants of immunization coverage disparities among health districts in Burkina Faso: a multiple case study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Measles vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Heat-stable measles vaccine produced by spray drying

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

A simple technique for reducing edge effect in cell-based assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Photoinactivation of measles virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Different effects of MgC1-2 and MgSO-4 on the thermostability of viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Comparison of the effect of gluconate, lactose, and xylitol on bone recalcification in calcium-deficient rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Citrate-mediated disaggregation of rotavirus particles in RotaTeq vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Stabilization of measles virus for vaccine formulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

Vaccine delivery management

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

based on heuristic

inferred from DOI database lookup

Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.079

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.04.079

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38423122&oldid=2033539206"